Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fufang Shiwei Capsules is a Traditional Chinese Medicine (TCM) formulation developed by Shanxi Buchang Pharmaceutical. It is a compound herbal preparation primarily indicated for the treatment of various urinary system diseases, including acute and chronic glomerulonephritis, pyelonephritis, cystitis, and urethritis. The formulation typically consists of extracts from *Pyrrosia lingua* (Shiwei), *Astragalus membranaceus* (Huangqi), *Sophora flavescens* (Kushen), and *Polygonum aviculare* (Bianxu). Its therapeutic mechanism is based on TCM principles of clearing heat, drying dampness, and promoting diuresis to alleviate symptoms such as painful, frequent, or urgent urination and lower extremity edema. The product is approved and widely marketed in China for these indications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fufang shiwei capsules.